
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 10.930 | 18.350 | 7.420 |
Shares | 89.070 | 96.200 | 7.130 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 12.261 | 19.991 |
Price to Book | 1.108 | 3.937 |
Price to Sales | 0.630 | 2.312 |
Price to Cash Flow | 7.589 | 15.597 |
Dividend Yield | 1.403 | 1.427 |
5 Years Earnings Growth | 7.378 | 11.176 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 78.220 | 94.419 |
Financial Services | 7.970 | 9.125 |
Consumer Defensive | 4.790 | 3.262 |
Industrials | 4.760 | 3.164 |
Consumer Cyclical | 4.250 | 7.903 |
Number of long holdings: 36
Number of short holdings: 4
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Georgia Capital | GB00BF4HYV08 | 7.67 | 1,914.00 | +3.24% | |
Fresenius SE | DE0005785604 | 6.93 | 43.8600 | +0.85% | |
3SBio | KYG8875G1029 | 6.92 | 19.64 | -0.30% | |
Fagron | BE0003874915 | 5.29 | 21.90 | +1.15% | |
Dermapharm | DE000A2GS5D8 | 5.21 | 35.10 | +1.30% | |
Eurofins Scientific | FR0014000MR3 | 4.93 | 57.46 | -0.52% | |
Krka | SI0031102120 | 4.88 | 185.50 | 0.00% | |
Medios AG | DE000A1MMCC8 | 4.84 | 11.9600 | -0.99% | |
Ontex Group | BE0974276082 | 4.61 | 7.74 | +0.91% | |
AGFA Gevaert | BE0003755692 | 4.58 | 1.02 | +2.00% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
ACATIS Fair Value Modulor Vermogeni | 299.03M | -6.98 | -4.40 | 2.93 | ||
ACATIS Fair Value Modulor Vermogens | 299.03M | -6.77 | -3.76 | 3.51 | ||
FU Fonds Multi Asset Fonds P | 105.75M | -6.58 | 3.15 | 6.26 | ||
H A Aktien Small Cap EMU A | 76.96M | 6.87 | 2.43 | 6.34 | ||
H A Aktien Small Cap EMU C I | 76.96M | 7.07 | 3.01 | 6.91 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review